Form 4: Amicus Therapeutics CFO Simon Harford Reports Stock Disposal
SEC Form 4 Filing
Simon N.R. Harford, CFO of Amicus Therapeutics, disposed of 12,529 shares of common stock on August 21, 2024, to cover tax obligations.
Summary
- On August 21, 2024, Simon N.R. Harford, the Chief Financial Officer of Amicus Therapeutics, disposed of 12,529 shares of common stock.
- The transaction was executed at a price of $12.09 per share.
- Following the transaction, Harford directly owns 151,836 shares of Amicus Therapeutics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a routine transaction by a company officer. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it provides insight into insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date of the stock disposal transaction. |
| 08/23/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.